Drawing for LUNG INFINITE BIO-DIGITAL TWIN

USPTO serial 79462280

LUNG INFINITE BIO-DIGITAL TWIN

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
GADSON, SHARI B.
Law office
TMO LAW OFFICE 120

What this means

Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months. Monitor TSDR for the examiner's first action. No filing is required until an office action or other requirement is issued.

Status 638: Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months.

Need help with LUNG INFINITE BIO-DIGITAL TWIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Research, surveying, photographic, cinematographic, audiovisual, signalling, inspecting, or teaching apparatus and instruments; biochips; chip-like devices to hold biochip or any biological preparation; chromatography apparatus for laboratory use; diffraction apparatus; microscopes on chip; lasers, not for medical purposes; testing devices for safety of materials; safety testing devices; devices for testing immune and chronic response; recorded and downloadable media, blank digital or analogue recording and storage media; computer software related to testing devices for biological safety of materials; computer programs for testing devices, testing devices for biological safety of materials, safety testing devices, devices for testing immune or chronic response; computer programs for discovery of mechanisms of toxicity of materials, chemicals, drugs, vaccines or similar; computer programs for discovery of effects of materials, chemicals, drugs, vaccines or similar on functioning of cells or systems; computer programs for testing drug efficiency; computer programs for testing vaccine efficiency; computer programs for testing efficiency of pharmaceutical compounds; computer programs to recover images from microscope on chip; devices and computer programs to compare toxic effects on living cells and tissues for optimization of materials, compounds or vaccines, devices to monitor evolution of early stages of disease in terms of cell responses; chip-like and biochip-like devices for prediction of chronic or slowly-evolving diseases; organ-on-a-chip (OoC) systems; computational, modelling and machine learning tools; laboratory instruments and apparatus for in vitro testing and biomedical data analysis and safety validation.ACTIVE—
042Scientific or technological services in the fields of medicine, pharmacy, drug discovery, mechanisms of pathology, or material safety testing; scientific or technological services related to development of therapeutics; scientific or technological services related to predictive disease models, in particular models of lung disease, lung cancer, lung fibrosis or neurodegeneration; scientific services related to discovery of mechanisms of toxicity of materials, chemicals, drugs, vaccines or similar; scientific services related to discovery of effects of materials, chemicals, drugs, vaccines or similar on functioning of cells or systems; scientific services related to optimization of efficiency of materials, chemicals, drugs, vaccines or similar; research and design; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software; technical advisory services regarding material safety and toxicity; scientific research in the field of scientific devices; scientific research in the field of testing devices for determining biological safety of materials; research relating to optical devices, microscopes, spectroscopy; biological research; research in the field of chemistry; research in the field of physics; research in the field of biotechnology; research in the field of microscopy; design of microscopes and equipment for microscopes; technical consultancy relating to materials, medicines, vaccines, chemicals safety and toxicity; technical consultancy relating to safety testing devices, testing devices for biological safety of materials, safety testing devices, devices for testing immune and chronic response; material testing; material safety testing; testing of biological safety; testing of response of biological preparations to materials, compounds, chemicals and pharmaceutical preparations; testing of immune and chronic response to various materials, compounds, chemicals and pharmaceutical preparations; validation studies relating to safety of materials, pharmaceutical preparations, vaccines and medicines [testing services]; development of computer software; development of computer software related to testing devices for safety of materials; development of computer software related to analysis of material toxicity; development of computer programs to recover images from microscope on chip; development of computer programs for image analysis to unravel interaction of compounds with components of biological preparations; development of devices and computer programs to compare toxic effects on living cells and tissues for optimization of materials, compounds or vaccines; development of devices to monitor evolution of early stages of disease in terms of cell responses; development of biochips; development of microscopes, development of biomicroscopes; research in the field of mathematics; research in the field of medicine; research in the field of pharmacy; research in the field of drug discovery; research in the field of mechanisms of pathology.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 16, 2026DOCKASSIGNED TO EXAMINER—
Nov 10, 2026DOCKASSIGNED TO EXAMINER—
Nov 9, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 9, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 5, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance